Company Management

OMass Therapeutics

Biotechnology Research Oxford, Oxfordshire, United Kingdom 85 employees

Employees: 85
Contacts: 2
Emails: 2
Phones: 1

omasstech.com LinkedIn Crunchbase

OMass Therapeutics Overview

Headquarters: Oxford, Oxfordshire, United Kingdom
Phone Number: Available in AeroLeads
Website: omasstech.com
Industry: Biotechnology Research
Employees: 85
Founded: 2016
Funding: 12.5M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Oxford

About OMass Therapeutics

OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures and British Patient Capital.

OMass Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

OMass Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Magdalena Jonikas	Partner at Syncona Limited		View
Laia Malet Sanz	Director, Medicinal Chemistry at Omass Therapeutics		View
Birgitte Volck		Denmark	Email
Jonathan Montagu	President & Chief Executive Officer at Hotspot Therapeutics, Inc.	Cambridge, Massachusetts, United States	Email Phone